The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine.

Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing, and commercializing potentially best-in-class medicines for serious and rare diseases, today ...

According to MarketsandMarkets™, The agriculture biotechnology market is projected to grow from USD 92.19 billion in 2025 to USD 144.25 ...

FDA requests additional information on a formulation component - HUNTSVILLE, AL, Nov. 03, 2025 (GLOBE NEWSWIRE) -- (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing ...

INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today ...

LBS Centre for Science and Technology; Palayam, Nandavanam, has invited applications for the State Eligibility Test (SET), January 2026. SET is an eligibility test for selection as higher secondary ...

Positive end of Phase I meeting and agreement reached with FDA on pivotal study design for TSC-101 Dosed first solid tumor patients with multiplex TCR-T therapy; paused further enrollment to ...

The acceptance establishes Category III CPT® codes X505T–X510T, creating a dedicated mechanism for providers to report autologous heterogeneous skin construct graft procedures in the clinical use of ...

Since 2019, breakthroughs in synthetic biology, AI-driven protein design, and precision fermentation have revitalized the ...

Matica Biotechnology, a United States contract development and manufacturing organization under Korea’s Cha Biotech, said Monday that it had signed a partnershi ...

Synthetic biology is ready for the next developmental milestone and America’s leadership depends on getting the financing right.